Disopyramide Capsules 100mg (Rythmodan® / リスモダンカプセル100mg)

JPY ¥4,300

Japanese Antiarrhythmic Agent (Disopyramide 100mg). Oral capsule for premature contractions, paroxysmal supraventricular tachycardia, and atrial fibrillation. 100 capsules [10 capsules (PTP) x 10]. Mfd. by Cheplapharm K.K., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥3,956
10 - 19 12% JPY ¥3,784
20 + 18% JPY ¥3,526
SKU: RYT-100-CAP Category:

Description

Product Overview / 商品概要

Rythmodan Capsules 100mg (リスモダンカプセル100mg)
Generic: Disopyramide / ジソピラミド
Therapeutic Category: Antiarrhythmic Agent – Disopyramide Preparation / 不整脈治療剤 ジソピラミド製剤
Manufactured by: Cheplapharm K.K. / チェプラファーム株式会社

Composition & Specification / 組成・規格

Active Ingredient: Disopyramide (JP) 100mg per capsule / 1カプセル中 日局ジソピラミド 100mg
Additives: Contents: Lactose hydrate, Corn starch, Talc, Magnesium stearate; Capsule shell: Gelatin, FD&C Blue No. 1, Sodium lauryl sulfate, Sodium hydrogen sulfite, Titanium oxide, Yellow ferric oxide / 内容物:乳糖水和物、トウモロコシデンプン、タルク、ステアリン酸マグネシウム カプセル:ゼラチン、青色1号、ラウリル硫酸ナトリウム、亜硫酸水素ナトリウム、酸化チタン、黄色三二酸化鉄
Appearance: Size 3 capsule with green cap and yellow body; Weight: 234mg; Identification code: RURY
外観: 緑色キャップ 黄色ボディの3号カプセル 重量:234mg 識別コード:RURY

Indications / 効能効果

EN: For the following conditions when other antiarrhythmic drugs cannot be used or are ineffective: Premature contractions, Paroxysmal supraventricular tachycardia, Atrial fibrillation
JA: 下記の状態で他の抗不整脈薬が使用できないか、又は無効の場合 期外収縮、発作性上室性頻脈、心房細動

Dosage and Administration / 用法用量

EN: Rythmodan Capsules 100mg: Usually, 1 capsule (100mg) orally 3 times daily for adults. Dose may be adjusted according to symptoms.
JA: リスモダンカプセル100mg:通常、成人1回1カプセル(100mg)1日3回経口投与、症状により適宜増減する。

Contraindications / 禁忌

EN: Patients with severe atrioventricular block or severe sinoatrial block; patients with congestive heart failure; patients receiving sparfloxacin, moxifloxacin hydrochloride, lascufloxacin hydrochloride (injection), toremifene citrate, vardenafil hydrochloride hydrate, amiodarone hydrochloride (injection), eliglustat tartrate, fingolimod hydrochloride, or siponimod fumarate; patients with angle-closure glaucoma; patients with urinary retention tendency; patients with a history of hypersensitivity to any component of this product
JA: 高度の房室ブロック・高度の洞房ブロックのある患者、うっ血性心不全のある患者、スパルフロキサシン・モキシフロキサシン塩酸塩・ラスクフロキサシン塩酸塩(注射剤)・トレミフェンクエン酸塩・バルデナフィル塩酸塩水和物・アミオダロン塩酸塩(注射剤)・エリグルスタット酒石酸塩・フィンゴリモド塩酸塩・シポニモドフマル酸塩を投与中の患者、閉塞隅角緑内障の患者、尿貯留傾向のある患者、本剤の成分に対し過敏症の既往歴のある患者

Regulatory Information / 規制情報

Approval No.: 21400AMZ00028
Sales Started: April 1978 / 1978年4月
Classification Code: 872129
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年

Packaging / 包装

Main Package (for sale): 100 capsules [10 capsules (PTP) x 10] / 100カプセル[10カプセル(PTP)×10]
Other Available Packages (by special order): 100 capsules [10 capsules (PTP) x 10]; 500 capsules [10 capsules (PTP) x 50]

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Disopyramide Capsules 100mg (Rythmodan® / リスモダンカプセル100mg)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Disopyramide Capsules 100mg (Rythmodan®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.